Back to dataset

National Oesophago-Gastric Cancer Audit, 2017Annex 10 (Chemotherapy) from National Oesophago-Gastric Cancer Audit, Open Data - 2017

You're previewing the first 4 rows of this file.

Audit year(s)	Cancer Alliance code	Cancer Alliance name	N EOX	% EOX	N ECX	% ECX	N HCX	% HCX	N CAPECITABINE + CISPLATIN	% CAPECITABINE + CISPLATIN	N CAPECITABINE + OXALIPLATIN	% CAPECITABINE + OXALIPLATIN	N Other combinations	% Other combinations
Apr 2014 - Mar 2016	A01	Cheshire and Merseyside	69	56.1%	7	5.7%	6	4.9%	11	8.9%	13	10.6%	17	13.8%
Apr 2014 - Mar 2016	A02	East Midlands	98	51.6%	22	11.6%	10	5.3%	19	10.0%	0	0.0%	41	21.6%
Apr 2014 - Mar 2016	A03	East of England	90	34.5%	69	26.4%	13	5.0%	9	3.4%	11	4.2%	69	26.4%
Apr 2014 - Mar 2016	A04	Greater Manchester	124	70.5%	11	6.3%	13	7.4%	0	0.0%	0	0.0%	28	15.9%